Medicamen Biotech Limited (NSE:MEDICAMEQ)

Market Cap	5.28B
Revenue (ttm)	1.63B
Net Income (ttm)	71.08M
Shares Out	n/a
EPS (ttm)	5.59
PE Ratio	74.33
Forward PE	n/a
Dividend	1.00 (0.24%)
Ex-Dividend Date	Sep 19, 2024

Volume	27,411
Average Volume	33,466
Open	424.90
Previous Close	421.60
Day's Range	412.95 - 426.00
52-Week Range	375.05 - 630.00
Beta	1.03
RSI	46.55
Earnings Date	May 29, 2025

About Medicamen Biotech

Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-malarial, vitamins and supplements, other generics, and pain management. The company was incorporated in 1993 and is based in New Delhi, India.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 378
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MEDICAMEQ

Financial Performance

In 2024, Medicamen Biotech's revenue was 1.63 billion, a decrease of -9.35% compared to the previous year's 1.79 billion. Earnings were 71.08 million, a decrease of -34.97%.